Source: CityTodayNews
It is easy to see that it matters. It has already obtained emergency use authorization (EUA) in India.
It is applying for EUA in the Philippines. It is in Phase 3 clinical trials with 25800 volunteers in India.
Bharath Biotech has a history of vaccine manufacture of other types of vaccines (not a first timer). According to the manufacturer, the vaccine is made on a platform known for its safety ("The vaccine is being manufactured using Vero cell platform, ..)
Read more at:
The American pharmaceutical company OCUGEN (makes treatments for eyes) has an understanding with Bharath Biotech to manufacutre and distribute the vaccine in the USA. "Ocugen will be responsible for clinical development, regulatory approval and commercialization for the U.S. market"[Benzinga]
The existing vaccines are expensive for some countries requiring COVID-19 vaccines, and this is the other demography that Bharath Biotech is targeting. Furthermore, the jury is out as to the best vaccine for COVID-19 especially due to the various variants entering the scene.
More here:
No comments:
Post a Comment